Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?
Amyotrophic lateral sclerosis (ALS) is a fatal condition primarily characterized by the selective loss of upper and lower motor neurons. At present, the diagnosis and monitoring of ALS is based on clinical examination, electrophysiological findings, medical history, and exclusion of confounding diso...
Main Authors: | Robelin, Laura, Gonzalez De Aguilar, Jose Luis |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060749/ |
Similar Items
-
Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?
by: Henriques, Alexandre, et al.
Published: (2011) -
Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells
by: Nardo, Giovanni, et al.
Published: (2011) -
Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis
by: Henriques, Alexandre, et al.
Published: (2015) -
Smads as muscle biomarkers in amyotrophic lateral sclerosis
by: Si, Ying, et al.
Published: (2014) -
Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
by: Turner, Martin R, et al.
Published: (2015)